[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Vericiguat.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Vericiguat.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Vericiguat.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Vericiguat.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Thioridazine is combined with Vericiguat.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Vericiguat.]
[M02AX02, tolazoline, The risk or severity of adverse effects can be increased when Tolazoline is combined with Vericiguat.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the orthostatic hypotensive activities of Vericiguat.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Vericiguat.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Vericiguat.]
[C03AA06, trichlormethiazide, Vericiguat may increase the hypotensive activities of Trichlormethiazide.]
[C02BA01, trimethaphan, Vericiguat may increase the hypotensive activities of Trimethaphan.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Vericiguat.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Verapamil is combined with Vericiguat.]
[C04AX07, vincamine, Vericiguat may increase the hypotensive activities of Vincamine.]
[C03BA10, xipamide, Vericiguat may increase the hypotensive activities of Xipamide.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Vericiguat.]
[G04BE10, avanafil, The risk or severity of hypotension can be increased when Avanafil is combined with Vericiguat.]
[L01EX05, regorafenib, The metabolism of Vericiguat can be decreased when combined with Regorafenib.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Vericiguat.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Vericiguat.]
[C08CA13, lercanidipine, The risk or severity of adverse effects can be increased when Lercanidipine is combined with Vericiguat.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Sildenafil is combined with Vericiguat.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Vericiguat.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Canagliflozin is combined with Vericiguat.]
[C08EA02, bepridil, The risk or severity of adverse effects can be increased when Bepridil is combined with Vericiguat.]
[C02KX05, riociguat, The therapeutic efficacy of Vericiguat can be increased when used in combination with Riociguat.]
[C02KX04, macitentan, Vericiguat may increase the hypotensive activities of Macitentan.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Vericiguat.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Acebutolol is combined with Vericiguat.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Vericiguat.]
[C02CC01, bethanidine, Vericiguat may increase the hypotensive activities of Bethanidine.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Empagliflozin is combined with Vericiguat.]
[J02AC05, isavuconazole, The metabolism of Vericiguat can be decreased when combined with Isavuconazole.]
[B01AC27, selexipag, Vericiguat may increase the hypotensive activities of Selexipag.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Bromocriptine is combined with Vericiguat.]
[C08CA01, amlodipine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Vericiguat.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Bumetanide is combined with Vericiguat.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Vericiguat.]
[C07AA19, bupranolol, Vericiguat may increase the hypotensive activities of Bupranolol.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Vericiguat.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Vericiguat.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Vericiguat.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Vericiguat.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Vericiguat.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Nesiritide is combined with Vericiguat.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Captopril is combined with Vericiguat.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Carvedilol is combined with Vericiguat.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Vericiguat.]
[N03AX24, cannabidiol, The metabolism of Vericiguat can be decreased when combined with Cannabidiol.]
[C07AB08, celiprolol, Vericiguat may increase the hypotensive activities of Celiprolol.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Cilazapril is combined with Vericiguat.]
[C09CA06, candesartan, Vericiguat may increase the hypotensive activities of Candesartan.]
[C03BX03, cicletanine, Vericiguat may increase the hypotensive activities of Cicletanine.]
[C03AA09, cyclothiazide, Vericiguat may increase the hypotensive activities of Cyclothiazide.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Clevidipine is combined with Vericiguat.]
[C02AA06, methoserpidine, Vericiguat may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Opicapone is combined with Vericiguat.]
[C08CA17, levamlodipine, Vericiguat may increase the hypotensive activities of Levamlodipine.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Vericiguat.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Vericiguat.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Vericiguat.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Fenoldopam is combined with Vericiguat.]
[H04AA02, dasiglucagon, Vericiguat may increase the hypotensive activities of Dasiglucagon.]
[M01AG01, mefenamic acid, The metabolism of Vericiguat can be decreased when combined with Mefenamic acid.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Vericiguat.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Clomipramine is combined with Vericiguat.]
[S01EA04, clonidine, The risk or severity of adverse effects can be increased when Clonidine is combined with Vericiguat.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Vericiguat.]
[C02KB01, metyrosine, Vericiguat may increase the hypotensive activities of Metyrosine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Desflurane is combined with Vericiguat.]
[C08CA09, lacidipine, Vericiguat may increase the hypotensive activities of Lacidipine.]
[N07BC04, lofexidine, The risk or severity of adverse effects can be increased when Lofexidine is combined with Vericiguat.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Lisinopril is combined with Vericiguat.]
[C08CA11, manidipine, Vericiguat may increase the hypotensive activities of Manidipine.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Eplerenone is combined with Vericiguat.]
[C03AA07, cyclopenthiazide, Vericiguat may increase the hypotensive activities of Cyclopenthiazide.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Vericiguat.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Vericiguat.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Moexipril is combined with Vericiguat.]
[C03XA02, conivaptan, The risk or severity of adverse effects can be increased when Conivaptan is combined with Vericiguat.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Moxonidine is combined with Vericiguat.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Vericiguat.]
[C02CC04, debrisoquin, Vericiguat may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Vericiguat.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Nebivolol is combined with Vericiguat.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Vericiguat.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Aliskiren is combined with Vericiguat.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Diazoxide is combined with Vericiguat.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Diclofenamide is combined with Vericiguat.]
[C02DG01, pinacidil, Vericiguat may increase the hypotensive activities of Pinacidil.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Pipamperone is combined with Vericiguat.]
[C08CA03, isradipine, The risk or severity of adverse effects can be increased when Isradipine is combined with Vericiguat.]
[N02BA11, diflunisal, The metabolism of Vericiguat can be decreased when combined with Diflunisal.]
[C02DB01, dihydralazine, Vericiguat may increase the hypotensive activities of Dihydralazine.]
[B01AC21, treprostinil, Vericiguat may increase the hypotensive activities of Treprostinil.]
[C08DB01, diltiazem, The risk or severity of adverse effects can be increased when Diltiazem is combined with Vericiguat.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Quinapril is combined with Vericiguat.]
[B01AC07, dipyridamole, The risk or severity of hypotension can be increased when Dipyridamole is combined with Vericiguat.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Vericiguat.]
[N05AX08, risperidone, Vericiguat may increase the hypotensive activities of Risperidone.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Vericiguat.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Tadalafil is combined with Vericiguat.]
[C02KX02, ambrisentan, Vericiguat may increase the hypotensive activities of Ambrisentan.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Sevoflurane is combined with Vericiguat.]
[C09AA11, spirapril, Vericiguat may increase the hypotensive activities of Spirapril.]
[C07AB13, talinolol, Vericiguat may increase the hypotensive activities of Talinolol.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Terazosin is combined with Vericiguat.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Vericiguat.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Vericiguat.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Torasemide is combined with Vericiguat.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Vericiguat.]
[C02CA06, urapidil, Vericiguat may increase the hypotensive activities of Urapidil.]
[C08CA12, mepirodipine, The risk or severity of adverse effects can be increased when Barnidipine is combined with Vericiguat.]
[C09AA15, zofenopril, Vericiguat may increase the hypotensive activities of Zofenopril.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Vericiguat.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Iloprost is combined with Vericiguat.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Amifostine is combined with Vericiguat.]
[C08CA02, felodipine, The risk or severity of adverse effects can be increased when Felodipine is combined with Vericiguat.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Vericiguat.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Vericiguat.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Vericiguat.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Vericiguat.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Vericiguat.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Vericiguat.]
[C05AE01, nitroglycerin, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Vericiguat.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Vericiguat.]
[L01EX02, sorafenib, The metabolism of Vericiguat can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Vericiguat.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Vericiguat.]
[S01EX01, guanethidine, Vericiguat may increase the hypotensive activities of Guanethidine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Halothane is combined with Vericiguat.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Quetiapine is combined with Vericiguat.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Losartan is combined with Vericiguat.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Vericiguat.]
[C08CA10, nilvadipine, The risk or severity of adverse effects can be increased when Nilvadipine is combined with Vericiguat.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Perindopril is combined with Vericiguat.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Hydralazine is combined with Vericiguat.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Vericiguat.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Vericiguat.]
[C02AC06, rilmenidine, Vericiguat may increase the hypotensive activities of Rilmenidine.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Vericiguat.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Vericiguat.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Paclitaxel is combined with Vericiguat.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Vericiguat.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Indapamide is combined with Vericiguat.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Indoramin is combined with Vericiguat.]
[C07AA01, alprenolol, Vericiguat may increase the hypotensive activities of Alprenolol.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Vericiguat.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Vericiguat.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Imidapril is combined with Vericiguat.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Vericiguat.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Vericiguat.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Vericiguat.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Vericiguat.]
[C02KD01, ketanserin, Vericiguat may increase the hypotensive activities of Ketanserin.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Vericiguat.]
[V03AC03, deferasirox, The metabolism of Vericiguat can be decreased when combined with Deferasirox.]
[N04BC09, rotigotine, The risk or severity of adverse effects can be increased when Rotigotine is combined with Vericiguat.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Labetalol is combined with Vericiguat.]
[C02AA05, deserpidine, Vericiguat may increase the hypotensive activities of Deserpidine.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Vericiguat.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Vericiguat is combined with Levodopa.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Vericiguat.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Vericiguat.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Vericiguat.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Vericiguat.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Vericiguat.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Vericiguat.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Vericiguat.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Methyldopa is combined with Vericiguat.]
[V04CG05, methylene blue, Methylene blue may increase the orthostatic hypotensive activities of Vericiguat.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Vericiguat.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Metoprolol is combined with Vericiguat.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Vericiguat.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Vericiguat.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vericiguat.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Vericiguat.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Vericiguat.]
[B02BX05, eltrombopag, The metabolism of Vericiguat can be decreased when combined with Eltrombopag.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Vericiguat.]
[N03AB05, fosphenytoin, The metabolism of Vericiguat can be decreased when combined with Fosphenytoin.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Nadolol is combined with Vericiguat.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Vericiguat.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Vericiguat is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Vericiguat.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Vericiguat.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Levosimendan is combined with Vericiguat.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Vericiguat.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Telmisartan is combined with Vericiguat.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Vericiguat.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Nicardipine is combined with Vericiguat.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Nifedipine is combined with Vericiguat.]
[M02AA17, niflumic acid, The metabolism of Vericiguat can be decreased when combined with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Vericiguat.]
[C08CA06, nimodipine, The risk or severity of adverse effects can be increased when Nimodipine is combined with Vericiguat.]
[C08CA07, nisoldipine, The risk or severity of adverse effects can be increased when Nisoldipine is combined with Vericiguat.]
[C08CA08, nitrendipine, The risk or severity of adverse effects can be increased when Nitrendipine is combined with Vericiguat.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Vericiguat.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Vericiguat.]
[C02DD01, nitroprusside, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Vericiguat.]
[C02KX01, bosentan, Vericiguat may increase the hypotensive activities of Bosentan.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Vericiguat.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Oxprenolol is combined with Vericiguat.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Papaverine is combined with Vericiguat.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Vericiguat.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Penbutolol is combined with Vericiguat.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Vericiguat.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Vericiguat.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Vericiguat.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Vericiguat.]
[V03AB36, phentolamine, The risk or severity of adverse effects can be increased when Phentolamine is combined with Vericiguat.]
[N03AB02, phenytoin, The metabolism of Vericiguat can be decreased when combined with Phenytoin.]
[C08CX01, mibefradil, Vericiguat may increase the hypotensive activities of Mibefradil.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Pindolol is combined with Vericiguat.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Eprosartan is combined with Vericiguat.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Irbesartan is combined with Vericiguat.]
[C03AA05, polythiazide, Vericiguat may increase the hypotensive activities of Polythiazide.]
[C07AB01, practolol, Vericiguat may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Vericiguat.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Vericiguat.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Vericiguat.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Vericiguat.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Propofol is combined with Vericiguat.]
[C07AA05, propranolol, The risk or severity of adverse effects can be increased when Propranolol is combined with Vericiguat.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Epoprostenol is combined with Vericiguat.]
[N05AX12, aripiprazole, Aripiprazole may increase the hypotensive activities of Vericiguat.]
[C02AA01, rescinnamine, Vericiguat may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Vericiguat.]
[J04AB02, rifampin, The metabolism of Vericiguat can be decreased when combined with Rifampicin.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Vericiguat.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Vericiguat.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vericiguat.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Vericiguat.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Vericiguat.]
